The race is on to produce innovative AI-enabled products and services. Determining who owns or controls the IP rights of a new technology can get messy if contracts do not exist or do not contain clear IP terms
Topic: CanadaSubscribe to Canada
AI and Drug Development: The current landscape and IP considerations
AI has the potential to revolutionise the pharmaceuticals industry. Key considerations include how to monetise these innovations and what types of IP protection are available for AI-influenced drug discoveries?
Submissions now open to Artificial Intelligence Stakeholders: Canada’s Copyright Act Review
As the protection and use of artificial intelligence technologies is significantly influenced by both the Patent Act and Copyright Act, this is an important opportunity for artificial intelligence stakeholders.
Will artificial intelligence need human rights training?
The Financial Post interviews Norton Rose Fulbright Canada LLP’s patent and trademark lawyer Maya Medeiros on Artificial Intelligence’s discriminatory biases.
Artificial intelligence and intellectual property considerations
We discuss the technological impact that artificial intelligence (AI) will have on intellectual property rights in the corporate world.
Opportunity for Artificial Intelligence stakeholders to shape Copyright Act
On December 14, 2017, Innovation, Science and Economic Development Canada announced that Parliament will undertake a review of Canada’s Copyright Act.